查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1590818

基因组编辑市场：按技术、应用和最终用户划分 - 2025-2030 年全球预测

Genome Editing Market by Technology (Antisense, CRISPR, Talen), Application (Cell Line Engineering, Genetic Engineering), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年基因组编辑市场价值为108亿美元，预计到2024年将达到165.4亿美元，复合年增长率为53.22%，到2030年将达到2142.2亿美元。

基因组编辑是一种修改生物体 DNA 的科学方法，在从农业到医疗保健的广泛应用中获得了大力支持。这项技术对于创造具有特定所需性状的基因改造生物、解决农作物抗病性和医疗保健治疗方法开发进展等问题至关重要。对基因组编辑的需求源于其透过实现精确且具有成本效益的基因改造来解决粮食安全和遗传疾病等紧迫世界问题的潜力。其主要用途是在农业领域开发抗害虫产量的作物，以及在医疗保健领域以基因疗法为中心治疗遗传性疾病。此外，用于生质燃料生产的工业生物技术和环境技术正在取得突破。

主要市场统计
基准年[2023] 108亿美元
预测年份 [2024] 165.4亿美元
预测年份 [2030] 2142.2亿美元
复合年增长率（%） 53.22%

基因组编辑市场的成长主要是由对先进治疗解决方案的需求不断增长、生物技术的持续进步以及对遗传疾病的日益了解所推动的。最新的机会包括扩大 CRISPR 在治疗和作物改良计划中的应用，以支持永续和有弹性的粮食系统。投资研究机构或与研究机构合作的公司可以利用基因组编辑的专利新技术，获得监管部门的核准，并儘早进入新兴市场。对公司的主要建议是专注于开发更高精度和更少脱靶效应的基因编辑工具，并扩大伙伴关係以增强研发能力。

然而，市场面临重大挑战，包括对基因改造的伦理担忧、严格的法规环境以及可能影响市场采用的潜在社会经济差异。公众意识和道德辩论可能会限制某些地区对该技术的接受，需要透明的沟通和社区参与努力。创新应着重于开发下一代编辑工具，例如碱基编辑器，改善治疗应用的交付机制，并透过与政策制定者的积极对话解决监管瓶颈。基因组编辑市场的特点是技术快速发展，如果能够熟练地应对伦理和监管环境，就可以为公司的创新提供肥沃的土壤。

市场动态：揭示快速发展的基因组编辑市场的关键市场洞察

供需的动态交互作用正在改变基因组编辑市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 政府资助和基因组学计划数量的增加
    • 拓展基因体学的应用领域
    • 感染疾病和癌症发生率高
    • 基因改造作物产量增加
  • 市场限制因素
    • 缺乏训练有素的专业人员
    • 基因研究的社会评估下降
  • 市场机会
    • 基因组编辑在专业医学的应用
    • 使用 CRISPR-Cas9 系统进行基因组编辑的进展
  • 市场挑战
    • 基因组分析设备高成本
    • 大量序列资料的安全存储

波特的五力：驾驭基因组编辑市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解基因组编辑市场的外部影响

外部宏观环境因素在塑造基因组编辑市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解基因组编辑市场的竞争状况

对基因组编辑市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵基因组编辑市场供应商绩效评估

FPNV定位矩阵是评估基因组编辑市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了基因组编辑市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对基因组编辑市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加政府资助和增加基因组学计划数量
      • 拓展基因体学的应用领域
      • 感染疾病和癌症发生率高
      • 基因改造作物产量增加
    • 抑制因素
      • 受过训练的专业人员数量有限
      • 公众对基因研究的负面看法
    • 机会
      • 基因组编辑在专业医学的应用
      • 使用 CRISPR-Cas9 系统进行基因组编辑的进展
    • 任务
      • 与基因组设备相关的高成本
      • 大量序列资料的安全存储
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 基因组编辑市场：依技术分类

  • 反义
  • 更脆的
  • 塔伦
  • 锌指核酸酶

第七章 基因组编辑市场：依应用分类

  • 细胞株工程
  • 基因工程
    • 动物基因工程
    • 植物基因工程

第 8 章 基因组编辑市场：依最终使用者划分

  • 学术和政府研究机构
  • 生物技术和製药公司
  • 合约调查机构

第九章 北美和南美基因组编辑市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章 亚太地区基因组编辑市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的基因组编辑市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abcam PLC
  • AgriGenome Labs Pvt. Ltd.
  • Beam Therapeutics Inc.
  • Biocompare, Inc.
  • Danaher Corporation
  • Editas Medicine, Inc.
  • GenScript Biotech Corporation
  • Lonza Group AG
  • Merck KGaA
  • OriGene Technologies, Inc.
  • PerkinElmer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sangamo Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • Verve Therapeutics, Inc.
Product Code: MRR-431C35F6C15D

The Genome Editing Market was valued at USD 10.80 billion in 2023, expected to reach USD 16.54 billion in 2024, and is projected to grow at a CAGR of 53.22%, to USD 214.22 billion by 2030.

Genome editing, the scientific approach to modifying an organism's DNA, has gained significant traction in applications ranging from agriculture to health care. This technology is pivotal for its ability to create genetically modified organisms with specific desired traits, addressing issues such as disease resistance in crops and advancing therapeutic development in healthcare. The necessity of genome editing stems from its potential to solve pressing global issues, including food security and genetic disorders, by enabling precise and cost-effective genetic modifications. Its primary applications are in agriculture, for developing pest-resistant and higher-yield crops, and in healthcare, particularly in gene therapy to treat genetic conditions. Additionally, it's making strides in industrial biotechnology for biofuel production and environmental technology.

KEY MARKET STATISTICS
Base Year [2023] USD 10.80 billion
Estimated Year [2024] USD 16.54 billion
Forecast Year [2030] USD 214.22 billion
CAGR (%) 53.22%

Market growth in genome editing is primarily driven by increasing demand for advanced therapeutic solutions, continuous advancements in biotechnology, and a growing understanding of genetic diseases. The latest opportunities include expanding CRISPR applications in therapeutics and crop improvement programs to support sustainable and resilient food systems. Companies that invest in and partner with research institutions can leverage new patentable techniques in genome editing, gain regulatory approvals, and achieve early entry into emerging markets. Key recommendations for businesses would be to focus on developing gene editing tools with higher accuracy and fewer off-target effects, and the expansion of partnerships to enhance R&D capabilities.

However, the market faces significant challenges such as ethical concerns over genetic modifications, stringent regulatory environments, and potential socio-economic disparities impacting market adoption. Public perception and ethical debates could limit technology acceptance in some regions, necessitating transparent communication and community engagement initiatives. Innovation should focus on creating next-gen editing tools like base editors, improving delivery mechanisms for therapeutic applications, and addressing regulatory bottlenecks through proactive dialogue with policymakers. The genome editing market is characterized by rapid technological evolution, offering a fertile ground for businesses to innovate, provided they navigate ethical and regulatory landscapes adeptly.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genome Editing Market

The Genome Editing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising government funding and growth in the number of genomics Projects
    • Growing application areas of genomics
    • High prevalence of infectious diseases and cancer
    • Increasing production of genetically modified crops
  • Market Restraints
    • Limited availability of trained professionals
    • Adverse public perception of genetic research
  • Market Opportunities
    • Use of genome editing in specialized medicine
    • Advancements in genome editing with CRISPR-Cas9 system
  • Market Challenges
    • High cost associated with genomics equipment
    • Secure storage of large volumes of sequenced data

Porter's Five Forces: A Strategic Tool for Navigating the Genome Editing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genome Editing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genome Editing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genome Editing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genome Editing Market

A detailed market share analysis in the Genome Editing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genome Editing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genome Editing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genome Editing Market

A strategic analysis of the Genome Editing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genome Editing Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, AgriGenome Labs Pvt. Ltd., Beam Therapeutics Inc., Biocompare, Inc., Danaher Corporation, Editas Medicine, Inc., GenScript Biotech Corporation, Lonza Group AG, Merck KGaA, OriGene Technologies, Inc., PerkinElmer Inc., Regeneron Pharmaceuticals, Inc., Sangamo Therapeutics, Inc., Thermo Fisher Scientific Inc., and Verve Therapeutics, Inc..

Market Segmentation & Coverage

This research report categorizes the Genome Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Antisense, CRISPR, Talen, and Zinc Finger Nucleases.
  • Based on Application, market is studied across Cell Line Engineering and Genetic Engineering. The Genetic Engineering is further studied across Animal Genetic Engineering and Plant Genetic Engineering.
  • Based on End User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising government funding and growth in the number of genomics Projects
      • 5.1.1.2. Growing application areas of genomics
      • 5.1.1.3. High prevalence of infectious diseases and cancer
      • 5.1.1.4. Increasing production of genetically modified crops
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of trained professionals
      • 5.1.2.2. Adverse public perception of genetic research
    • 5.1.3. Opportunities
      • 5.1.3.1. Use of genome editing in specialized medicine
      • 5.1.3.2. Advancements in genome editing with CRISPR-Cas9 system
    • 5.1.4. Challenges
      • 5.1.4.1. High cost associated with genomics equipment
      • 5.1.4.2. Secure storage of large volumes of sequenced data
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genome Editing Market, by Technology

  • 6.1. Introduction
  • 6.2. Antisense
  • 6.3. CRISPR
  • 6.4. Talen
  • 6.5. Zinc Finger Nucleases

7. Genome Editing Market, by Application

  • 7.1. Introduction
  • 7.2. Cell Line Engineering
  • 7.3. Genetic Engineering
    • 7.3.1. Animal Genetic Engineering
    • 7.3.2. Plant Genetic Engineering

8. Genome Editing Market, by End User

  • 8.1. Introduction
  • 8.2. Academic & Government Research Institutes
  • 8.3. Biotechnology & Pharmaceutical Companies
  • 8.4. Contract Research Organizations

9. Americas Genome Editing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Genome Editing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Genome Editing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. AgriGenome Labs Pvt. Ltd.
  • 3. Beam Therapeutics Inc.
  • 4. Biocompare, Inc.
  • 5. Danaher Corporation
  • 6. Editas Medicine, Inc.
  • 7. GenScript Biotech Corporation
  • 8. Lonza Group AG
  • 9. Merck KGaA
  • 10. OriGene Technologies, Inc.
  • 11. PerkinElmer Inc.
  • 12. Regeneron Pharmaceuticals, Inc.
  • 13. Sangamo Therapeutics, Inc.
  • 14. Thermo Fisher Scientific Inc.
  • 15. Verve Therapeutics, Inc.

LIST OF FIGURES

  • FIGURE 1. GENOME EDITING MARKET RESEARCH PROCESS
  • FIGURE 2. GENOME EDITING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENOME EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GENOME EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GENOME EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENOME EDITING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENOME EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENOME EDITING MARKET DYNAMICS
  • TABLE 7. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENOME EDITING MARKET SIZE, BY ANTISENSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENOME EDITING MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENOME EDITING MARKET SIZE, BY TALEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENOME EDITING MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENOME EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENOME EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENOME EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENOME EDITING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENOME EDITING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES GENOME EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2023